Lenvima (generic name Lenvatinib) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. Lenvima was developed by Eisai and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
Lenvima (Lenvatinib) uses and indications:
Lenvatinib is approved for the treatment of differentiated thyroid cancer.
Levantinib was also approved for the treatment of advanced renal cell carcinoma.
DOSAGE FORM & STRENGTH:
Lenvima (Lenvatinib) 24 mg wholesaler
Lenvima (Lenvatinib) 20 mg distributor
Lenvima (Lenvatinib) 14 mg supplier
Lenvima (Lenvatinib) 10 mg wholesaler
Rasso Swiss Pharma can supply you with all dosage of Lenvima (Lenvatinib) .